Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast CancerDan Jian(Army Medical University), Hao Luo(Army Medical University)Evidence-based Complementary and Alternative MedicineApril 13, 202210.1155/2022/6048017Cited by 9SaveCiteExport RISWatch citationsRelated PapersA randomized phase 2 trial of apatinib vs observation as maintenance treatment following firstline induction chemotherapy in extensive stage small cell lung cancer|Investigational New Drugs|2019|26